{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:52:07Z","timestamp":1791913927538,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJYXZDXK-001A"],"award-info":[{"award-number":["TJYXZDXK-001A"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["LHGJ20230264"],"award-info":[{"award-number":["LHGJ20230264"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171995"],"award-info":[{"award-number":["82171995"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["22ZYYYQ02"],"award-info":[{"award-number":["22ZYYYQ02"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.113971","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:32:21Z","timestamp":1750386741000},"page":"113971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Homotypic biomimetic nanotheranostics enhance locoregional Cherenkov radiation-induced photodynamic therapy and ferroptosis in early bone metastases"],"prefix":"10.1016","volume":"385","author":[{"given":"Rui","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","article-title":"Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis","volume":"16","author":"Ye","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113971_bb0010","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113971_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","article-title":"Bone metastasis in prostate cancer: emerging therapeutic strategies","volume":"8","author":"Sturge","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113971_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrurol.2015.90","article-title":"Targeting bone metastases in prostate cancer: improving clinical outcome","volume":"12","author":"Body","year":"2015","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113971_bb0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.biomaterials.2011.10.039","article-title":"Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging","volume":"33","author":"Xing","year":"2012","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113971_bb0030","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1021\/acsnano.7b03197","article-title":"Targeting osteocytes to attenuate early breast cancer bone metastasis by theranostic upconversion nanoparticles with responsive plumbagin release","volume":"11","author":"Qiao","year":"2017","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113971_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.semnuclmed.2016.07.003","article-title":"18F-NaF-PET\/CT and 99mTc-MDP bone scintigraphy in the detection of bone metastases in prostate cancer","volume":"46","author":"Langsteger","year":"2016","journal-title":"Semin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113971_bb0040","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J. Nucl. Med."},{"issue":"20","key":"10.1016\/j.jconrel.2025.113971_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400114","article-title":"Cell membrane-camouflaged chitosan-polypyrrole nanogels co-deliver drug and gene for targeted chemotherapy and bone metastasis inhibition of prostate cancer","volume":"13","author":"Yu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113971_bb0050","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jamaoncol.2018.4044","article-title":"Targeted alpha therapy, an emerging class of cancer agents a review","volume":"4","author":"Parker","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Sig. Transduct. Target. Therapy"},{"issue":"10276","key":"10.1016\/j.jconrel.2025.113971_bb0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(21)00237-3","article-title":"[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial","volume":"397","author":"Hofman","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113971_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(23)00638-1","article-title":"Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study","volume":"25","author":"Sathekge","year":"2024","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113971_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S1470-2045(22)00642-8","article-title":"Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial","volume":"23","author":"B\u00e9nard","year":"2022","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113971_bb0075","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2967\/jnumed.123.265484","article-title":"Specific uptake in the bone marrow causes high absorbed red marrow doses during [177Lu]Lu-DOTATATE treatment","volume":"64","author":"Hemmingsson","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2025.113971_bb0080","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/IJN.S442768","article-title":"Nanoparticles for the Treatment of bone metastasis in breast cancer: Recent advances and challenges","volume":"19","author":"Yu","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113971_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120404","article-title":"Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges","volume":"265","author":"Gao","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113971_bb0090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.7150\/thno.40489","article-title":"SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113971_bb0095","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","article-title":"New insights into \u201cpermeability\u201d as in the enhanced permeability and retention effect of cancer nanotherapeutics","volume":"11","author":"Nel","year":"2017","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12943-024-02161-1","article-title":"Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment","volume":"23","author":"Guan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2025.113971_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102174","article-title":"Cerenkov radiation shining a light for cancer theranostics","volume":"55","author":"Teng","year":"2024","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113971_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41565-018-0142-y","article-title":"Is Cherenkov luminescence bright enough for photodynamic therapy?","volume":"13","author":"Pratx","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"33","key":"10.1016\/j.jconrel.2025.113971_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202302777","article-title":"Amplification of cerenkov luminescence using semiconducting polymers for cancer theranostics","volume":"33","author":"Rosenkrans","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"52","key":"10.1016\/j.jconrel.2025.113971_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904894","article-title":"A \u201cmissile-detonation\u201d strategy to precisely supply and efficiently amplify cerenkov radiation energy for cancer theranostics","volume":"31","author":"Yu","year":"2019","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.jconrel.2025.113971_bb0125","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1039\/D0BM00778A","article-title":"A chlorin-lipid nanovesicle nucleus drug for amplified therapeutic effects of lung cancer by internal radiotherapy combined with the Cerenkov radiation-induced photodynamic therapy","volume":"8","author":"Cai","year":"2020","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113971_bb0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00259-022-05978-4","article-title":"Chlorin e6-loaded goat milk-derived extracellular vesicles for Cerenkov luminescence-induced photodynamic therapy","volume":"50","author":"Guo","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.113971_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101984","article-title":"A sequential dual-locked strategy with pH-responsive activation of photosensitizers and precise Cerenkov radiation delivery for cancer theranostics","volume":"52","author":"Wu","year":"2023","journal-title":"Nano Today"},{"issue":"40","key":"10.1016\/j.jconrel.2025.113971_bb0140","doi-asserted-by":"crossref","first-page":"21884","DOI":"10.1002\/anie.202107231","article-title":"Smart 131I-labeled self-illuminating photosensitizers for deep tumor therapy","volume":"60","author":"Guo","year":"2021","journal-title":"Angew. Chem.-Intern. Ed."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113971_bb0145","doi-asserted-by":"crossref","first-page":"19691","DOI":"10.1021\/acsnano.2c07286","article-title":"Recent progress and trends in X-ray-induced photodynamic therapy with low radiation doses","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0150","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/s41467-022-32054-0","article-title":"Organic phosphorescent nanoscintillator for low-dose X-ray-induced photodynamic therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0155","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1038\/s41467-024-52607-9","article-title":"Full-course NIR-II imaging-navigated fractionated photodynamic therapy of bladder tumours with X-ray-activated nanotransducers","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301326","article-title":"Internal light sources-mediated photodynamic therapy nanoplatforms: Hope for the resolution of the traditional penetration problem","volume":"13","author":"An","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113971_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1148\/131.2.291","article-title":"Long-term curative results of radiotherapy of patients with inoperable prostatic carcinoma. Erskine Memorial Lecture, 1978","volume":"131","author":"del Regato","year":"1979","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113971_bb0170","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033688","article-title":"Metastases in prostate cancer","volume":"9","author":"La Manna","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113971_bb0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113971_bb0180","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"225Ac-PSMA-617 for PSMA-targeted a-radiation therapy of metastatic castration-resistant prostate cancer","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113971_bb0185","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1039\/D0CS00384K","article-title":"Radiolabelling of nanomaterials for medical imaging and therapy","volume":"50","author":"Pellico","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113971_bb0190","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.110.075101","article-title":"Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention","volume":"51","author":"Vegt","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113971_bb0195","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113971_bb0200","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","article-title":"Elimination pathways of nanoparticles","volume":"13","author":"Poon","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113971_bb0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.actbio.2023.06.009","article-title":"Aggregation-induced emission photosensitizer\/bacteria biohybrids enhance Cerenkov radiation-induced photodynamic therapy by activating anti-tumor immunity for synergistic tumor treatment","volume":"167","author":"Zhu","year":"2023","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2967\/jnumed.120.260034","article-title":"Cerenkov luminescence imaging in prostate cancer: not the only light that shines","volume":"63","author":"Heuvel","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113971_bb0215","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00259-023-06142-2","article-title":"A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET\/CT imaging in suspicious prostate cancer","volume":"50","author":"Gao","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113971_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nnano.2016.301","article-title":"Utilizing the power of Cerenkov light with nanotechnology","volume":"12","author":"Shaffer","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113971_bb0225","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1021\/acsami.7b17902","article-title":"Activating TiO2 Nanoparticles: Gallium-68 serves as a high-yield photon emitter for cerenkov-induced photodynamic therapy","volume":"10","author":"Duan","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113971_bb0230","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"14","key":"10.1016\/j.jconrel.2025.113971_bb0235","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113971_bb0240","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acsnano.8b05860","article-title":"Ferrous-supply-regeneration nanoengineering for cancer-cell-specific ferroptosis in combination with imaging-guided photodynamic therapy","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113971_bb0245","article-title":"Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: novel insights and perspectives","volume":"18","author":"Wang","year":"2023","journal-title":"Asian J. Pharmac. Sci."},{"key":"10.1016\/j.jconrel.2025.113971_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216236","article-title":"Multimodal synergistic ferroptosis cancer therapy","volume":"522","author":"Singh","year":"2025","journal-title":"Coord. Chem. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113971_bb0255","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1021\/acs.nanolett.9b02904","article-title":"Triggered all-active metal organic framework: Ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy","volume":"19","author":"Meng","year":"2019","journal-title":"Nano Lett."},{"issue":"33","key":"10.1016\/j.jconrel.2025.113971_bb0260","doi-asserted-by":"crossref","first-page":"29579","DOI":"10.1021\/acsami.9b09671","article-title":"Fenton reaction-assisted photodynamic therapy for cancer with multifunctional magnetic nanoparticles","volume":"11","author":"Hou","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.jconrel.2025.113971_bb0265","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.7150\/thno.32867","article-title":"Ferroptosis promotes photodynamic therapy: supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0270","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12951-021-00952-y","article-title":"Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy","volume":"19","author":"Wang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"51","key":"10.1016\/j.jconrel.2025.113971_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207174","article-title":"Ferritin-hijacking nanoparticles spatiotemporally directing endogenous ferroptosis for synergistic anticancer therapy","volume":"34","author":"Zhu","year":"2022","journal-title":"Adv. Mater."},{"issue":"31","key":"10.1016\/j.jconrel.2025.113971_bb0280","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2321929121","article-title":"Iron regulatory protein 2 contributes to antimicrobial immunity by preserving lysosomal function in macrophages","volume":"121","author":"Cheng","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113971_bb0285","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1021\/jacs.4c00395","article-title":"Nanodrug hijacking blood transferrin for ferroptosis-mediated cancer treatment","volume":"146","author":"Zhang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.113971_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.124494","article-title":"Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy","volume":"389","author":"Zeng","year":"2020","journal-title":"Chem. Eng. J."},{"issue":"43","key":"10.1016\/j.jconrel.2025.113971_bb0295","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1002\/adma.201602173","article-title":"Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors","volume":"28","author":"Sun","year":"2016","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.jconrel.2025.113971_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808200","article-title":"Biomimetic metal-organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy","volume":"31","author":"Min","year":"2019","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113971_bb0305","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1021\/acsami.3c01176","article-title":"Nucleus-targeting manganese dioxide nanoparticles coated with the human umbilical cord mesenchymal stem cell membrane for cancer cell therapy","volume":"15","author":"Xie","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.jconrel.2025.113971_bb0310","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.jconrel.2025.113971_bb0315","doi-asserted-by":"crossref","first-page":"11112","DOI":"10.1021\/acsnano.1c01063","article-title":"Antiangiogenesis combined with inhibition of the hypoxia pathway facilitates low-Dose, X-ray-induced photodynamic therapy","volume":"15","author":"Jiang","year":"2021","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.jconrel.2025.113971_bb0320","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1021\/nn102711d","article-title":"Multifunctional triblock nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing","volume":"5","author":"Patil","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113971_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113638","article-title":"Poly-lysine-modified recombinant protein nanocages for effective delivery of small activating RNA","volume":"382","author":"Xu","year":"2025","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2025.113971_bb0330","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","article-title":"Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic Cancer Cell Membranes","volume":"16","author":"Zhu","year":"2016","journal-title":"Nano Lett."},{"issue":"45","key":"10.1016\/j.jconrel.2025.113971_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206286","article-title":"Bioactive iridium nanoclusters with glutathione depletion ability for enhanced sonodynamic-triggered ferroptosis-like cancer cell death","volume":"34","author":"Nie","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113971_bb0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/TCRM.S2707","article-title":"Zoledronic acid in the management of metastatic bone disease","volume":"4","author":"Polascik","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113971_bb0345","first-page":"172","article-title":"The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review","volume":"33","author":"Widyadharma","year":"2024","journal-title":"Adv. Psych. Neurol."},{"key":"10.1016\/j.jconrel.2025.113971_bb0350","first-page":"221","article-title":"Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma","volume":"17","author":"Fu","year":"2022","journal-title":"Bioact. Mater."},{"issue":"24","key":"10.1016\/j.jconrel.2025.113971_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311760","article-title":"Efficient delivery of lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for glioblastoma therapy","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:16:36Z","timestamp":1778944596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":71,"alternative-id":["S0168365925005929"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113971","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homotypic biomimetic nanotheranostics enhance locoregional Cherenkov radiation-induced photodynamic therapy and ferroptosis in early bone metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113971"}}